Author:
Bergman Mats A.,Granlund David,Rudholm Niklas
Funder
Swedish Competition Authority
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference33 articles.
1. Almarsdottir, A. B., Morgall, J. M., & Björnsdottir, I. (2000). A question of emphasis: Efficiency or equality in the provision of pharmaceuticals. The International Journal of Health Planning and Management, 15(2), 149–161.
2. Almarsdottir, A. B., Morgall, J. M., & Grimsson, A. (2000). Cost containment of pharmaceutical use in Iceland: The impact of liberalization and user charges. Journal of Health Services Research & Policy,. doi: 10.1177/135581960000500209 .
3. Andersson, K., Petzold, M., Sonesson, C., Lonnroth, K., & Carlsten, A. (2006). Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time-series analysis of cost, volume and cost per volume trends in Sweden 1986–2002. Health Policy, 79, 231–243.
4. Anell, A., & Hjelmgren, J. (2002). Implementing competition in the pharmacy sector: Lessons from Iceland and Norway. Applied Health Economics and Health Policy, 1, 149–156.
5. Anell, A. (2004). Nya villkor för apotek och läkemedelsförsäljning - Erfarenheter från Danmark, Island och Norge (in Swedish). IHE Working Paper 2004:2.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献